uniQure (QURE) Short Interest Ratio & Short Volume $17.48 +0.10 (+0.58%) As of 09:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock uniQure Short Interest DatauniQure (QURE) has a short interest of 9.73 million shares. This marks a 3.51% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.5, indicating that it would take 8.5 days of the average trading volume of 1.35 million shares to cover all short positions.Current Short Interest9,730,000 sharesPrevious Short Interest9,400,000 sharesChange Vs. Previous Month+3.51%Dollar Volume Sold Short$157.43 millionShort Interest Ratio8.5 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares54,870,000 sharesPercentage of Shares Shorted17.73%Today's Trading Volume39,529 sharesAverage Trading Volume1,345,441 sharesToday's Volume Vs. Average3% Short Selling uniQure? Sign up to receive the latest short interest report for uniQure and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartQURE Short Interest Over TimeQURE Days to Cover Over TimeQURE Percentage of Float Shorted Over Time uniQure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20259,730,000 shares $157.43 million +3.5%N/A8.5 $16.18 7/31/20259,400,000 shares $130.85 million +8.8%18.0%7.1 $13.92 7/15/20258,640,000 shares $120.61 million -1.0%N/A5.9 $13.96 6/30/20258,730,000 shares $121.70 million +13.8%16.7%5.2 $13.94 6/15/20257,670,000 shares $117.66 million +3.0%14.7%4.2 $15.34 5/31/20257,450,000 shares $108.47 million +5.8%16.0%4.2 $14.56 5/15/20257,040,000 shares $93.28 million +27.1%15.2%4 $13.25 4/30/20255,540,000 shares $81.77 million +5.3%N/A3.3 $14.76 4/15/20255,260,000 shares $50.76 million +19.8%11.3%3.8 $9.65 3/31/20254,390,000 shares $46.53 million +43.9%9.5%3.8 $10.60 Get the Latest News and Ratings for QURE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for uniQure and its competitors with MarketBeat's FREE daily newsletter. 3/15/20253,050,000 shares $43.31 million +18.7%6.6%2.9 $14.20 2/28/20252,570,000 shares $33.78 million +5.3%5.5%1.2 $13.15 2/15/20252,440,000 shares $34.60 million -23.8%5.3%1.1 $14.18 1/31/20253,200,000 shares $50.37 million -8.8%N/A1.5 $15.74 1/15/20253,510,000 shares $49.10 million +3.5%N/A1.7 $13.99 12/31/20243,390,000 shares $59.87 million -21.2%N/A1.6 $17.66 12/15/20244,300,000 shares $66.22 million +32.3%10.1%2.1 $15.40 11/30/20243,250,000 shares $19.40 million +2.5%7.6%1.9 $5.97 11/15/20243,170,000 shares $19.67 million -5.4%7.4%4.6 $6.21 10/31/20243,350,000 shares $19.16 million -41.5%7.4%5.1 $5.72 10/15/20245,730,000 shares $32.32 million +8.9%12.7%8.4 $5.64 9/30/20245,260,000 shares $25.93 million +23.2%11.7%2.6 $4.93 9/15/20244,270,000 shares $24.17 million -5.3%9.5%1.5 $5.66 8/31/20244,510,000 shares $26.38 million +4.6%10.0%1.6 $5.85 8/15/20244,310,000 shares $29.01 million +12.8%9.6%1.5 $6.73 7/31/20243,820,000 shares $29.26 million +20.1%8.5%1.4 $7.66 7/15/20243,180,000 shares $28.97 million +22.8%N/A1.2 $9.11 6/30/20242,590,000 shares $11.60 million -1.2%N/A1.1 $4.48 6/15/20242,620,000 shares $12.81 million -11.8%N/A4.5 $4.89 5/31/20242,970,000 shares $14.70 million +8.0%N/A4 $4.95 5/15/20242,750,000 shares $13.92 million -5.2%N/A3.3 $5.06 4/30/20242,900,000 shares $12.79 million +15.5%6.7%3.2 $4.41 4/15/20242,510,000 shares $11.90 million +1.2%5.9%2.6 $4.74 3/31/20242,480,000 shares $12.90 million -51.8%5.8%2.4 $5.20 3/15/20245,150,000 shares $26.63 million +15.0%12.1%4.7 $5.17 2/29/20244,480,000 shares $25.76 million +4.9%10.4%4 $5.75 2/15/20244,270,000 shares $23.40 million +15.1%9.9%3.9 $5.48 1/31/20243,710,000 shares $20.63 million +26.6%8.7%3.2 $5.56 1/15/20242,930,000 shares $18.11 million -1.4%6.9%2.3 $6.18 12/31/20232,970,000 shares $20.11 million -11.3%7.0%2.4 $6.77 12/15/20233,350,000 shares $27.70 million -11.1%7.9%2.7 $8.27 11/30/20233,770,000 shares $25.56 million +1.1%8.9%2.9 $6.78 11/15/20233,730,000 shares $24.82 million +18.4%8.8%2.9 $6.66 10/31/20233,150,000 shares $17.96 million -3.4%7.4%2.6 $5.70 10/15/20233,260,000 shares $21.32 million +1.6%7.7%3 $6.54 9/30/20233,210,000 shares $21.54 million -15.8%7.6%3.1 $6.71 9/15/20233,810,000 shares $30.18 million +60.8%8.6%3.7 $7.92 8/31/20232,370,000 shares $20.64 million +0.4%5.3%2.2 $8.71 8/15/20232,360,000 shares $21.03 million +8.3%5.3%2.6 $8.91 7/31/20232,180,000 shares $22.61 million +9.6%5.0%2.3 $10.37 7/15/20231,990,000 shares $21.67 million -17.4%4.6%2.3 $10.89 6/30/20232,410,000 shares $27.62 million -36.1%5.6%3 $11.46 6/15/20233,770,000 shares $71.67 million +3.9%8.8%5 $19.01 5/31/20233,630,000 shares $70.02 million +3.1%8.5%7 $19.29 5/15/20233,520,000 shares $76.24 million +6.3%8.2%6.4 $21.66 4/30/20233,310,000 shares $64.25 million -0.9%7.9%6.2 $19.41 4/15/20233,340,000 shares $65.30 million -10.2%7.9%6.4 $19.55 3/31/20233,720,000 shares $74.92 million +1.1%8.8%6.6 $20.14 3/15/20233,680,000 shares $70.95 million +1.9%9.3%6.6 $19.28 2/28/20233,610,000 shares $75.67 million +8.4%9.1%6.1 $20.96 2/15/20233,330,000 shares $67.70 million +2.5%8.4%4.8 $20.33 1/31/20233,250,000 shares $69.06 million +6.9%8.0%4.8 $21.25 1/15/20233,040,000 shares $70.13 million +8.6%7.4%4.4 $23.07 12/30/20222,800,000 shares $63.48 million +4.9%6.9%4 $22.67 12/15/20222,670,000 shares $61.62 million -12.8%6.5%3.9 $23.08 11/30/20223,060,000 shares $80.97 million +7.8%7.5%4.4 $26.46 11/15/20222,840,000 shares $62.20 million -5.0%6.9%4.3 $21.90 10/31/20222,990,000 shares $55.67 million -0.3%7.2%5 $18.62 10/15/20223,000,000 shares $56.40 million -7.1%7.2%4.5 $18.80 9/30/20223,230,000 shares $60.59 million +9.1%7.8%4.9 $18.76 9/15/20222,960,000 shares $59.88 million -1.0%7.1%4.2 $20.23 8/31/20222,990,000 shares $58.42 million -10.2%7.2%4 $19.54 8/15/20223,330,000 shares $69.20 million -4.9%8.0%4.5 $20.78 7/31/20223,500,000 shares $88.73 million -2.5%8.5%4.8 $25.35 7/15/20223,590,000 shares $84.98 million -13.3%8.7%5.4 $23.67 6/30/20224,140,000 shares $77.17 million +10.7%9.9%6.1 $18.64 6/15/20223,740,000 shares $52.66 million -2.4%9.0%5.9 $14.08 5/31/20223,830,000 shares $55.00 million +2.7%9.2%7.4 $14.36 5/15/20223,730,000 shares $53.38 million +16.9%8.9%7.1 $14.31 4/30/20223,190,000 shares $47.66 million -2.5%7.7%5.9 $14.94 4/15/20223,270,000 shares $61.31 million -3.0%7.9%6.2 $18.75 3/31/20223,370,000 shares $60.90 million +4.3%8.1%6.6 $18.07 3/15/20223,230,000 shares $48.68 million +6.6%7.8%5.8 $15.07 2/28/20223,030,000 shares $51.48 million +2.7%7.3%4.4 $16.99 2/15/20222,950,000 shares $51.24 million -2.6%7.1%4.4 $17.37 1/31/20223,030,000 shares $54.69 million -5.3%8.0%4.8 $18.05 1/15/20223,200,000 shares $64.67 million +11.5%8.4%5.2 $20.21 12/31/20212,870,000 shares $59.52 million +22.1%7.5%4.8 $20.74 12/15/20212,350,000 shares $67.56 million +3.5%6.2%4.2 $28.75 11/30/20212,270,000 shares $63.22 million -1.3%6.0%4.1 $27.85 11/15/20212,300,000 shares $71.48 million +2.2%6.0%3.8 $31.08 10/29/20212,250,000 shares $68.56 million -9.3%5.9%3.8 $30.47 10/15/20212,480,000 shares $74.55 million -13.3%6.5%4.1 $30.06 9/30/20212,860,000 shares $91.55 million +43.7%7.5%4.9 $32.01 9/15/20211,990,000 shares $72.40 million -10.4%5.3%3.5 $36.38 8/31/20212,220,000 shares $64.38 million -22.1%6.4%4.9 $29.00 8/13/20212,850,000 shares $83.11 million -2.7%8.2%7.5 $29.16 7/30/20212,930,000 shares $85.00 million +5.0%8.5%7.8 $29.01 7/15/20212,790,000 shares $75.55 million -11.2%7.9%7.1 $27.08 6/30/20213,140,000 shares $96.71 million -10.0%8.9%7.8 $30.80 6/15/20213,490,000 shares $120.27 million -2.5%9.9%7.8 $34.46 5/28/20213,580,000 shares $124.33 million -10.1%10.2%8.3 $34.73 5/14/20213,980,000 shares $126.17 million -3.4%11.3%8.9 $31.70 4/30/20214,120,000 shares $140.29 million -2.6%11.7%8.4 $34.05 4/15/20214,230,000 shares $147.54 million +11.9%N/A8.8 $34.88 3/31/20213,780,000 shares $125.84 million +17.4%10.1%8 $33.29 3/15/20213,220,000 shares $109.35 million +5.9%8.6%5.7 $33.96 2/26/20213,040,000 shares $112.48 million +2.4%8.2%5.5 $37.00 2/12/20212,970,000 shares $113.07 million -5.4%8.0%5.3 $38.07 1/29/20213,140,000 shares $112.66 million -6.0%8.5%6 $35.88 1/15/20213,340,000 shares $127.19 million -3.2%9.0%6.5 $38.08 12/31/20203,450,000 shares $128.20 million +19.8%9.3%6.8 $37.16 12/15/20202,880,000 shares $133.72 million +4.7%7.8%5.9 $46.43 11/30/20202,750,000 shares $129.94 million +8.7%7.4%6.6 $47.25 11/15/20202,530,000 shares $109.42 million -11.9%6.8%6.3 $43.25 10/30/20202,870,000 shares $115.52 million -12.5%7.7%7.4 $40.25 10/15/20203,280,000 shares $116.18 million -18.0%9.3%7.9 $35.42 9/30/20204,000,000 shares $147.32 million +8.7%11.4%9.3 $36.83 9/15/20203,680,000 shares $142.31 million +1.4%10.5%5.9 $38.67 QURE Short Interest - Frequently Asked Questions What is uniQure's current short interest? Short interest is the volume of uniQure shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 9,730,000 shares of QURE short. Learn More on uniQure's current short interest. What is a good short interest ratio for uniQure? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. QURE shares currently have a short interest ratio of 8.0. Learn More on uniQure's short interest ratio. Which institutional investors are shorting uniQure? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of uniQure: Nomura Holdings Inc., Group One Trading LLC, 683 Capital Management LLC, Jane Street Group LLC, Caption Management LLC, Walleye Capital LLC, Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is uniQure's short interest increasing or decreasing? uniQure saw a increase in short interest in August. As of August 15th, there was short interest totaling 9,730,000 shares, an increase of 3.5% from the previous total of 9,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does uniQure's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to uniQure: MoonLake Immunotherapeutics (9.72%), Apellis Pharmaceuticals, Inc. (16.05%), Scholar Rock Holding Corporation (16.09%), Arrowhead Pharmaceuticals, Inc. (9.39%), Viking Therapeutics, Inc. (24.47%), Amneal Pharmaceuticals, Inc. (3.30%), Xenon Pharmaceuticals Inc. (8.94%), Kymera Therapeutics, Inc. (10.64%), Crinetics Pharmaceuticals, Inc. (14.76%), Ultragenyx Pharmaceutical Inc. (8.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short uniQure stock? Short selling QURE is an investing strategy that aims to generate trading profit from uniQure as its price is falling. QURE shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against uniQure? A short squeeze for uniQure occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QURE, which in turn drives the price of the stock up even further. How often is uniQure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QURE, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies MoonLake Immunotherapeutics Short Interest Apellis Pharmaceuticals Short Interest Scholar Rock Short Interest Arrowhead Pharmaceuticals Short Interest Viking Therapeutics Short Interest Amneal Pharmaceuticals Short Interest Xenon Pharmaceuticals Short Interest Kymera Therapeutics Short Interest Crinetics Pharmaceuticals Short Interest Ultragenyx Pharmaceutical Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QURE) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding uniQure N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share uniQure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
